PubMed:19048115 / 1214-1462 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T8 0-248 Sentence denotes As expected, tumors and cell lines with NF1 defects lacked mutations in KRAS or BRAF but showed Ras pathway activation based on immunohistochemical detection of phosphorylated MAPK (primary tumors) or increased levels of GTP-bound Ras (cell lines).

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
5577 13-19 DiseaseOrPhenotypicFeature denotes tumors MESH:D009369
5578 40-43 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5579 72-76 GeneOrGeneProduct denotes KRAS NCBIGene:3845
5580 80-84 GeneOrGeneProduct denotes BRAF NCBIGene:673
5581 96-99 GeneOrGeneProduct denotes Ras NCBIGene:3845
5582 176-180 GeneOrGeneProduct denotes MAPK NCBIGene:5594
5583 190-196 DiseaseOrPhenotypicFeature denotes tumors MESH:D009369
5584 221-224 ChemicalEntity denotes GTP MESH:D006160
5585 231-234 GeneOrGeneProduct denotes Ras NCBIGene:3845

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T52 13-19 GeneOrGeneProduct denotes tumors
T53 24-28 GeneOrGeneProduct denotes cell
T54 29-34 GeneOrGeneProduct denotes lines
T55 40-43 GeneOrGeneProduct denotes NF1
T56 44-51 GeneOrGeneProduct denotes defects
T57 52-58 GeneOrGeneProduct denotes lacked
T58 59-68 GeneOrGeneProduct denotes mutations
T59 72-76 GeneOrGeneProduct denotes KRAS
T60 80-84 GeneOrGeneProduct denotes BRAF
T61 108-118 GeneOrGeneProduct denotes activation
T62 119-124 GeneOrGeneProduct denotes based
T63 176-180 GeneOrGeneProduct denotes MAPK
T64 190-196 GeneOrGeneProduct denotes tumors
T65 236-240 GeneOrGeneProduct denotes cell
T66 241-246 GeneOrGeneProduct denotes lines

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T29 24-28 GeneOrGeneProduct denotes cell
T30 29-34 GeneOrGeneProduct denotes lines
T31 40-43 GeneOrGeneProduct denotes NF1
T32 72-76 GeneOrGeneProduct denotes KRAS
T33 80-84 GeneOrGeneProduct denotes BRAF
T34 176-180 GeneOrGeneProduct denotes MAPK
T35 236-240 GeneOrGeneProduct denotes cell
T36 241-246 GeneOrGeneProduct denotes lines

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T8 13-19 DiseaseOrPhenotypicFeature denotes tumors D009369
T9 190-196 DiseaseOrPhenotypicFeature denotes tumors D009369

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T16 40-43 GeneOrGeneProduct denotes NF1
T17 72-76 GeneOrGeneProduct denotes KRAS
T18 80-84 GeneOrGeneProduct denotes BRAF
T19 176-180 GeneOrGeneProduct denotes MAPK

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T15 40-43 DiseaseOrPhenotypicFeature denotes NF1 0018975

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T14 13-19 DiseaseOrPhenotypicFeature denotes tumors DISEASE|D009369
T16 190-196 DiseaseOrPhenotypicFeature denotes tumors DISEASE|D009369

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T13 13-19 DiseaseOrPhenotypicFeature denotes tumors D009369
T14 190-196 DiseaseOrPhenotypicFeature denotes tumors D009369

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 221-224 ChemicalEntity denotes GTP http://purl.obolibrary.org/obo/CHEBI_37565|http://purl.obolibrary.org/obo/CHEBI_15996

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T1 221-224 ChemicalEntity denotes GTP http://purl.obolibrary.org/obo/CHEBI_15996|http://purl.obolibrary.org/obo/CHEBI_37565
T19 176-180 GeneOrGeneProduct denotes MAPK
T18 80-84 GeneOrGeneProduct denotes BRAF
T17 72-76 GeneOrGeneProduct denotes KRAS
T16 40-43 GeneOrGeneProduct denotes NF1
T50555 190-196 DiseaseOrPhenotypicFeature denotes tumors D009369
T53594 13-19 DiseaseOrPhenotypicFeature denotes tumors D009369

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T15 40-43 DiseaseOrPhenotypicFeature denotes NF1 0018975